AI Startup Latest Funding Deal: Cohere raised $500M Series D round

Artificial Intelligence | Machine Learning | Machine Perception Menten AI | A Quantum Leap in Protein Design

Consumer, Enterprise, Protein-Based Drugs and Enzymes, Biotechnology, Chemical, Healthcare, Pharmaceutical San Francisco, CA, United States

Artificial Intelligence | Machine Learning | Machine Perception

Menten AI | A Quantum Leap in Protein Design

Protein-Based Drugs and Enzymes, Biotechnology, Chemical, Healthcare, Pharmaceutical

San Francisco, CA, United States

Menten uses machine learning and quantum computing to design proteins for therapeutic and industrial purposes. This is a paradigm shift in drug discovery and enzyme engineering that could improve the lives of millions of people around the world. The team has made significant progress toward their goal including developing the first fully scalable quantum algorithm for peptide and protein design and created the world's first peptide designed on a quantum computer.

Menten’s quantum approach aims to overcome the scalability challenges that limit classical methods in computational protein design to significantly improve accuracy and reduce development time. Menten’s goal is to create the computational tools required to deliver on the promise of protein-based medicine and biocatalysis.